GVR Report cover MRI Contrast Media Agents Market Size, Share & Trends Report

MRI Contrast Media Agents Market Size, Share & Trends Analysis Report By Product Type (Paramagnetic Agents, Superparamagnetic Agents), By Application , By End-user, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453107
  • Number of Pages: 0
  • Format: Electronic (PDF)

Market Synopsis

MRI contrast media agents are widely used to identify the presence of tumors, aneurysms, and other abnormalities in the tissues. In 1981, the first MRI contrast agent, ferric chloride was used to identify abnormalities in the GI tract. Later gadolinium compound was identified and is said to be the gold standard of MRI contrast media. Newer agents are constantly being identified and investigated. The extremely stringent guideline is laid for the clinical use of such agents, which makes their use perilous. Each contrast agent follows a unique route of administration, right from the intravenous route to oral administration. They are categorized based on their chemical composition, magnetic properties, safety, efficacy, pharmacokinetics and pharmacodynamics, and their imaging property. This market holds a high growth potential due to the enormous research and development in this space to develop contrast media agents with reduced ill effects, minimized occurrence of adverse reactions, minimal dosing, and improved imaging efficacy.

MRI Contrast Media Agents Market Segmentation



Product Type

  • Paramagnetic Agents
  • Superparamagnetic Agents


  • Gastrointestinal
  • Intravenous
  • Hepatobiliary
  • Reticuloendothelial


  • Hospitals
  • Diagnostic Imaging Center


  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


Market Influencer

MRI scans are growing at a quicker rate across the globe and so is the use of these contrast media agents. Studies suggest that ~50-ton gadolinium contrast agents are used annually across the globe, creating a market space of ~1 billion dollars. The use of this agent is related to its unparallel advantages of increased vascular permeability, negligible waiting time before scans, high shelf stability, higher throughput, and high sensitivity to motion artifacts. Manganese-based contrast agents is also a type of paramagnetic agent, which is been highly researched in current times. On the other hand, superparamagnetic agents include iron-containing contrast agents such as ferumoxides, ferumoxtran, and ferumoxsil among others.

These agents have the dynamics to identify the progressions of brain tumor, liver cancer, or breast cancer and establish improved guidance during surgical intervention. Contrast media Enhanced MRI procedures are likely to increase in the future as the application of MRI expands and is made available to most patients across the globe and as the information obtained from a single contrast injection. However, variation in practice by end users, calls for greater standardization of protocols and utilization of the latest diagnostic algorithms.

The key players operating in the MRI contrast media agents market include Bayer AG, GE Healthcare LLC, Guerbet GmbH, Bracco Imaging Spa, Miltenyi Biotec B.V. & Co. Kg, Amag Pharmaceuticals among others.




This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.